Skye Bioscience, Inc. Other Long-term Debt, Current
Skye Bioscience, Inc. (SKYE) had Other Long-term Debt, Current of $0 as of 2023-12-31, per its 10-K filed 2024-03-22.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities
us-gaap:OtherLongTermDebtCurrent · last filed 2024-03-22
- 2023-12-31: Other Long-term Debt, Current $0.00.
- 2022-12-31: Other Long-term Debt, Current $1.85M; Other Long-term Debt, Current as first filed $0.00.
- 2022-09-30: Other Long-term Debt, Current $450.00K.
- 2022-06-30: Other Long-term Debt, Current $450.00K.
| Period end | Other Long-term Debt, Current | Other Long-term Debt, Current as first filed |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-22 | |
| 2022-12-31 | $1.85M 10-K · filed 2024-03-22 | $0.00 10-K · filed 2023-03-31 |
| 2022-09-30 | $450.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $450.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $450.00K 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $450.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $103.52K 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-28 | $64.06K 10-K · filed 2021-03-02 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |